To understand the initiation of metastasis associated with trastuzumab resistance in HER2-positive breast cancer, the expressions of EMT-activating transcription factors Slug, Snail, Twist2, and Zeb1 [19] were analyzed in SKBR3 and HCC1954 cells over time. Here, ERBB2 is linked to breast carcinoma.